Key result
Patient-specific iPSC-derived cardiomyocytes with a MYBPC3 R326Q mutation exhibited early hypertrophic cardiomyopathy features, including abnormal calcium handling and increased intracellular calcium.
Why the study?
Hypertrophic cardiomyopathy lacks efficient therapy methods, and patient-specific iPSC-derived cardiomyocytes offer new opportunities to model the disease and study its pathogenesis.
Patient-specific iPSC-derived cardiomyocytes can successfully model early features of hypertrophic cardiomyopathy, providing a platform for studying pathogenesis.
Answers are grounded in this paper and cite their sources.
iPSC-CMs may model early HCM mechanisms; hypothesis-generating and leaves open clinical translation.
Generation of patient-specific induced pluripotent stem cells (iPSCs) and their subsequent differentiation into cardiomyocytes opened new opportunities for studying pathogenesis of inherited cardiovascular diseases. One of these diseases is hypertrophic cardiomyopathy (HCM) for which no efficient therapy methods have been developed so far. In this study, the approach based on patient-specific iPSCs was applied to create a model of the disease. Genetic analysis of a hypertrophic cardiomyopathy patient revealed R326Q mutation in the MYBPC3 gene. iPSCs of the patient were generated and characterized. The cells were differentiated into cardiomyocytes together with the control iPSCs from a healthy donor. The patient's iPSC-derived cardiomyocytes exhibited early HCM features, such as abnormal calcium handling and increased intracellular calcium concentration. Therefore, cardiomyocytes obtained by directed differentiation of iPSCs from the HCM patient can be used as a model system to study HCM pathogenesis.
No takes yet. Share an insight, caveat, or question.
Dementyeva et al. (2019) studied Hypertrophic cardiomyopathy (n=1). Patient-specific induced pluripotent stem cells (iPSCs) vs. Control iPSCs from a healthy donor was evaluated on Early HCM features (abnormal calcium handling and increased intracellular calcium concentration). Patient-specific iPSC-derived cardiomyocytes with a MYBPC3 R326Q mutation exhibited early hypertrophic cardiomyopathy features, including abnormal calcium handling and increased intracellular calcium.
Synapse has enriched 10 related papers. Consider them for comparative context: